Sources | Names Used |
---|---|
CCLE, GDSC1000, GRAY, FIMM | Sorafenib |
CTRPv2 | sorafenib |
PharmacoGx | Sorafenib |
Database | Identifier |
---|---|
Smiles: | CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F |
Inchikey: | MLDQJTXFUGDVEO-UHFFFAOYSA-N |
Pubchem: | 216239 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | LYZ | GDSC1000 | pan-cancer | AAC | 0.34 | 4e-10 |
mRNA | HAL | CCLE | pan-cancer | AAC | 0.28 | 5e-10 |
mRNA | NMUR1 | GDSC1000 | pan-cancer | AAC | 0.34 | 6e-10 |
mRNA | C1orf162 | CCLE | pan-cancer | AAC | 0.3 | 6e-10 |
mRNA | MS4A6A | GDSC1000 | pan-cancer | AAC | 0.32 | 6e-10 |
mRNA | PRSS57 | GDSC1000 | pan-cancer | AAC | 0.34 | 7e-10 |
mRNA | RAB37 | CCLE | pan-cancer | AAC | 0.32 | 9e-10 |
mRNA | ADGRA2 | GDSC1000 | pan-cancer | AAC | 0.37 | 9e-10 |
mRNA | IRAK3 | GDSC1000 | pan-cancer | AAC | 0.33 | 1e-09 |
mRNA | NLRP3 | GDSC1000 | pan-cancer | AAC | 0.33 | 2e-09 |